期刊文献+

子宫内膜癌组织中PR及其亚型PRA、PRB的表达变化及意义 被引量:3

Clinical significance of progesterone receptors A and B expressions in endometrial carcinoma
下载PDF
导出
摘要 目的观察子宫内膜癌组织中孕激素受体(PR)及其亚型PRA、PRB表达变化,并探讨其临床意义。方法采用免疫组化SP法检测正常子宫内膜(正常组)、不典型增生内膜(不典型增生组)及子宫内膜样腺癌内膜(内膜癌组)组织中的PR及其亚型PRA、PRB表达情况。结果不典型增生组和内膜癌组PR阳性表达率明显低于正常组(P均<0.05),内膜癌组PR表达强度低于正常组和典型增生组(P均<0.05)。正常组、不典型增生组、内膜癌组PRA阳性表达率分别为100%、86.7%(13/15)、74.5%(41/55),PRB阳性表达率分别为100%、80%(12/15)和69.1%(38/55),内膜癌组PRA、PRB阳性表达率与正常组和不典型增生组相比均明显降低(P均<0.05)。正常组25例(82.5%)PRA、PRB表达强度相等,不典型增生组和内膜癌组分别为7例(46.7%)、12例(21.8%),内膜癌组明显低于正常组和不典型增生组,P均<0.01。内膜癌组只表达PRA或PRA占优势者24例(43.6%),明显多于正常组的5例(12.5%)和不典型增生组的4例(26.7%),P均<0.05。PRA表达与子宫内膜癌分化程度有关,PRB表达与子宫内膜癌分化程度、淋巴结转移和FIGO分期有关(P均<0.05)。结论子宫内膜癌患者子宫内膜组织中PR、PRA、PRB表达均明显降低。子宫内膜组织PR亚型表达缺失、比例失衡,尤其是PRB表达缺失可能与子宫内膜癌的发生有关。 Objective To study the changes of progesterone receptors A and B expression in endometrial carcinoma,and explore its clinical significance.Methods The expressions of PR,PRA and PRB were determined by immunohistochemical SP method in normal endometrium(normal group),atypical hyperplasia endometrium(atypical hyperplasia group) and endometrioid adenocarcinoma(endometrial carcinoma group).Results Significantly lower PR levels were found in endometrial carcinoma group and atypical hyperplasia group compared with normal group(P0.05).Endometrial carcinoma group had a significantly lower expressional intensity of PR than normal and atypical hyperplasia group(P0.05).The positive rate of PRA in normal,atypical hyperplasia and endometrial carcinoma group was 100%,86.7%(13/15),74.5%(41/55),respectively.The positive rate of PRB in three groups was 100%,80%(12/15)and 69.1%(38/55),respectively.The positive rates of PRA and PRB were both significantly lower in endometrial carcinoma group than the other two groups(P0.05).82.5% normal endometrium expressed both of the isoforms at similar levels,which was significantly higher than that in atypical hyperplasia and endometrial carcinoma group(46.7%,21.8%,P0.01).24 cases(43.6%) in endometrial carcinoma group expressed PRA only or a predominance of PRA,which was significantly higher than that in normal(5 cases,12.5%,P0.05)and atypical hyperplasia group(4 cases,26.7%,P0.05).In endometrioid adenocarcinoma,both PRA and PRB had a inverse correlation with histological grade(P0.05).The expression of PRB had relations with lymphatic metastasis and clinical stage(P0.05).Conclusion Significantly lower levels of PR,PRA and PRB can be found in endometrial carcinoma.Absence and disruption of relative PR isoform expression,especially the absence of PRB,may be involved in the pathogenesis of endometrial carcinoma.
出处 《山东医药》 CAS 北大核心 2011年第6期1-3,共3页 Shandong Medical Journal
关键词 子宫肿瘤 子宫内膜癌 孕激素受体 孕激素受体A 孕激素受体B uterus neoplasm endometrial carcinoma progesterone receptor progesterone receptor A progesterone receptor B
  • 相关文献

参考文献8

  • 1Conneely OM, Mulac-Jericevic B, Lydon JP. Progesterone-depend- ent regulation of female reproductive activity by two distinct proges- terone receptor isoforms[ J]. Steroids, 2003, 68 (13) : 771-778.
  • 2Horwltz KB, Alexander PS. In sire photolinked nuclear progesterone receptors of human breast cancer cells : subunit molecular weights after transformation and transloeation[J]. Endocrinology, 1983, 113 (6) : 2195-2201.
  • 3Smid-Koopman E, Kuhne LC, Hanekamp EE, et al: Progesterone- induced inhibition of growth and differential regulation of gene ex- pression in PRA- and/or PRB--expressing endometrial cancer cell lines[J]. J Soc Gynecol Invest, 2005, 12 (4) :285-292.
  • 4Arnett-Mansfield RL, de Fazio A, Wain GV, et al. Relative expression of progesterone receptors A and B in endometrloid cancers of the endometrium[ J]. Cancer Res, 2001,61 ( 11 ) :4576-4582.
  • 5Saito S, Ito K, Nagase S, et al. Progesterone receptor isoforms as a prognootic marker in human endometrial carcinoma[J]. Cancer Sci, 2006, 97(12) :1308-1314.
  • 6Miyamoto T, Watanabe J, Hata H, et al. Significance of progesterone receptor-A and -B expressions in endometrial adenocarcinoma [J].J Steroid Bioehem Mol Biol, 2004, 92 (3) : 111-118.
  • 7Sakaguchi H, Fujimoto J, Hong BL, et al. Drastic decrease of pro- gesterone receptor form B but not A mRNA re.fleets poor patient prognosis in endometrial eancersv [ J ]. Gyneeol Oneol, 2004, 93 (2) : 394-399.
  • 8Zafran N, Levin A, Goldman S, et al. Progesterone receptor'8 profile and the effect of the hormone and its derivatives on invasiveness and MMP2 secretion .in endometrlal carcinoma cell lines[J]. Harefuah, 2009,148 (7) :416-419,477.

同被引文献22

  • 1Kim J, Coffey D M, Creighton C J, et al. High-grade serous ovar- ian cancer arises from fallopia tube in a mouse model [ J ]. Proc Natl Acad Sci USA, 2012,109(10) :3921 -6.
  • 2Nik N N, Vang R, Shih I M, Kurman R J. Origin and pathogene- sis of pelvic ( ovarian, tubal, and primary peritoneal) serous car- cinoma[ J]. Annu Rev Pathol, 2013,9:27 - 45.
  • 3Karst A M, Jones P M, Vena N, et al. Cycliu E1 deregulation oc- curs early in secretory cell transformation to promote formation of fallopian tube-derived high-gade serous ovarian cancers [ J ].Cancer Res, 2014,74(4):1141 -52.
  • 4Kariagina A, Aupperlee M D, Haslam S Z. Progesterone receptor isoforms and proliferation in the rat mammary gland during devel- opment [ J ]. Endocrinology, 2007,148 ( 6 ) :2723 - 36.
  • 5Boonyaratanakornkit V, Bi Y, Rudd M, Edwards D P. The role and mechanism of progesterone receptor activation of extra-nuclear signaling pathways in regulating gene transcription and cell cycle progression[J]. Steroids, 2008,73(9 - 10) :922 -8.
  • 6Zafran N, Levin A, Goldman S, Shalev E. Progesterone receptor's profile and the efect of the hormone and its derivatives on invasive- ness and MMP2 secretion in endometrial carcinoma cell lnes [ J ]. Hareah, 2009,148(7) :416 -9.
  • 7Lenhard M, Tereza L, Heublein S, et al. Steroid hormone recep- tor expression in ovariancancer: progesterone receptor B as prog- nostic marker for patient survival [ J ]. BMC Cancer, 2012, 12 : 553.
  • 8Fauvet R, Dufoumet Etienne C, Poneelet C, et al. Effects of pro- gesterone and anti-progestin (mifepristone) treatment on prolifera- tion and apoptosis of the human ovarian cancer cell line, OVCAR- 3[J]. OneolRep, 2011,15(4):743-8.
  • 9黄俊辉,郭旭辉,申郑堂,蒋骑,何璇,张轶.孕激素受体亚型在乳腺癌中的表达及其临床意义[J].实用肿瘤杂志,2008,23(1):8-11. 被引量:1
  • 10田海侠,刘丽丽.子宫内膜癌中PR基因表达缺陷及其启动子区CpG岛甲基化的研究[J].现代预防医学,2010,37(10):1861-1864. 被引量:1

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部